ANAPTYSBIO, INC Cash And Cash Equivalents At Carrying Value

Quick Answer

ANAPTYSBIO, INC reported Cash And Cash Equivalents At Carrying Value of $238.20 million for the year ending 2025.

  • ANAPTYSBIO, INC showed an increase of +93.5% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
  • This data is from ANAPTYSBIO, INC's annual report (Form 10-K), filed with the SEC on March 3, 2026.
  • XBRL data for this metric is available from 2016 to 2025 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 10 years of available data (2016 to 2025), ANAPTYSBIO, INC's Cash And Cash Equivalents At Carrying Value has grown by 364.9%.
  • Historical annual values: Fiscal year 2025: $238.20 million | Fiscal year 2024: $123.08 million | Fiscal year 2023: $35.97 million | Fiscal year 2022: $71.31 million | Fiscal year 2021: $495.73 million | Fiscal year 2020: $250.46 million | Fiscal year 2019: $171.02 million | Fiscal year 2018: $113.60 million | Fiscal year 2017: $81.19 million | Fiscal year 2016: $51.23 million.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: